Zions Bancorporation, National Association’s Immunovant IMVT Stock Holding History

Zions Bancorporation, National Association’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.66K	Buy	+121	New	+$3.69K	﹤0.01%	1087

Other funds holding IMVT

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

DACS

Dymon Asia Capital (Singapore) Singapore $2.39B AUM 150.5% 1-Year Est. Return

Alchemi Wealth Essex, Connecticut $213M AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Zions Bancorporation, National Association's IMVT Position: Q2 2026 in Review

Zions Bancorporation, National Association opened a new position in Immunovant (IMVT) in Q2 2026: 121 shares worth $4.66K. The stake represents ﹤0.01% of the portfolio and ranks #1087 among its holdings.

38 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Zions Bancorporation, National Association held 121 shares of Immunovant worth $4.66K as of Q2 2026.
Immunovant was a new Zions Bancorporation, National Association position in Q2 2026.
Immunovant made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1087 holding.
38 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.